Urology · Germantown, TN
NPI
1508889817
Since 2006
Specialty
Urology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
7705 Poplar Ave, Suite 310b
Germantown, TN, 38138
Phone (901) 759-0101
Groups this clinician bills Medicare through
Medicare paid, 2024
$380K
81,287 services
Medicare patients, 2024
742
Average age 76
Drug cost, 2024
$275K
3,983 prescriptions
Company payments, 2025
$7,643
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William V Shappley was code J1071 (injection, testosterone cypionate, 1 mg), 70,202 times for 38 patients. In total William V Shappley billed 81,287 services in 121 codes, and Medicare paid $380K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 70,202 | 38 | $0.02 | $1,259 |
| 81003 Clinical Chemistry | Office | 1,364 | 605 | $2.17 | $2,957 |
| 82570 Clinical Chemistry | Office | 1,351 | 601 | $5.00 | $6,761 |
| 99213 Office E&M - Established | Office | 1,154 | 553 | $63.36 | $73K |
| 36415 Venipuncture Blood Collection | Office | 790 | 524 | $8.51 | $6,722 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 698 | 98 | $45.18 | $32K |
| 84153 Clinical Chemistry | Office | 589 | 414 | $17.69 | $10K |
| 51798 Ultrasound - Nonspecific | Office | 565 | 307 | $7.65 | $4,320 |
| 96372 Injection Administration | Office | 446 | 101 | $10.71 | $4,778 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 372 | 54 | $45.16 | $17K |
| 84154 Clinical Chemistry | Office | 231 | 136 | $17.55 | $4,055 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 230 | 72 | $36.06 | $8,294 |
| 99214 Office E&M - Established | Office | 185 | 172 | $83.74 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 129 | 118 | $12.90 | $1,664 |
| 84403 Clinical Chemistry | Office | 116 | 65 | $25.09 | $2,910 |
By year: 2022 $392K for 95,771 services; 2023 $373K for 71,466 services; 2024 $380K for 81,287 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,364 | 605 | $2.17 | $2,957 |
| 82570 Clinical Chemistry | 1,351 | 601 | $5.00 | $6,761 |
| 36415 Venipuncture Blood Collection | 790 | 524 | $8.51 | $6,722 |
| 84153 Clinical Chemistry | 589 | 414 | $17.69 | $10K |
| 84154 Clinical Chemistry | 231 | 136 | $17.55 | $4,055 |
| 84403 Clinical Chemistry | 116 | 65 | $25.09 | $2,910 |
| 84270 Clinical Chemistry | 111 | 62 | $21.12 | $2,345 |
| 84402 Clinical Chemistry | 111 | 62 | $24.75 | $2,748 |
| 88112 Surgical Pathology Examination | 84 | 74 | $21.16 | $1,778 |
| 82565 Clinical Chemistry | 69 | 66 | $4.95 | $341 |
Medicare prescription drug claims, 2024
In 2024, the drug William V Shappley prescribed most often to Medicare patients was Tamsulosin Hcl, with 958 prescriptions and refills. In total William V Shappley wrote 3,983 Medicare prescriptions that cost $275K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 958 | 2,697 | 358 | $13K |
| Dutasteride Generic | 566 | 1,572 | 199 | $19K |
| Oxybutynin Chloride Generic | 410 | 761 | 126 | $6,539 |
| Ciprofloxacin Hcl Generic | 383 | 383 | 252 | $2,254 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 201 | 201 | 147 | $1,466 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 139 | 139 | 95 | $2,441 |
| Finasteride Generic | 133 | 398 | 50 | $2,068 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 109 | 109 | 80 | $552 |
| Gemtesa Vibegron | 108 | 188 | 26 | $89K |
| Myrbetriq Mirabegron | 106 | 197 | 36 | $85K |
| Solifenacin Succinate Generic | 105 | 260 | 44 | $9,087 |
| Bethanechol Chloride Generic | 96 | 161 | 26 | $4,138 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 90 | 90 | 71 | $828 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 63 | 137 | 20 | $1,870 |
| Trimethoprim Generic | 62 | 90 | 22 | $3,404 |
Brand drugs: - claims; generic drugs: 3,639 claims; opioid claims: 227.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William V Shappley $7,643 ($7,643 in general payments such as food, travel and fees) from 16 companies. The largest payer was Accord Healthcare, Inc. with $6,075.
| Company | Payments | Amount |
|---|---|---|
| Accord Healthcare, Inc. | 10 | $6,075 |
| Teleflex LLC TFX | 6 | $573 |
| Sumitomo Pharma America, Inc. 4506.T | 9 | $325 |
| Procept Biorobotics Corporation PRCT | 2 | $198 |
| Coloplast Corp | 6 | $106 |
| C. R. Bard, Inc. & Subsidiaries BDX | 2 | $51.31 |
| Biotissue Holdings Inc. | 1 | $49.3 |
| Merck Sharp & Dohme LLC MRK | 2 | $48.88 |
| Pfizer Inc. PFE | 2 | $44.54 |
| Abbvie Inc. ABBV | 3 | $43.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.